Angiotensin II (ANGII), the major bioactive peptide of this system, is known to be involved in the advancement of CVD by inducing vasoconstrictive effects, endothelial dysfunction, inflammatory reactions, thrombosis and oxidative injuries9–11. Here, AGT is linked to endothelial dysfunction.